Virginia Lee

Virginia Lee

University of Pennsylvania

H-index: 228

North America-United States

Professor Information

University

University of Pennsylvania

Position

Professor of Pathology and Laboratory Medicine

Citations(all)

212286

Citations(since 2020)

69145

Cited By

170835

hIndex(all)

228

hIndex(since 2020)

128

i10Index(all)

913

i10Index(since 2020)

650

Email

University Profile Page

University of Pennsylvania

Research & Interests List

Neurodegenerative disorders

Top articles of Virginia Lee

Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.

Tauopathies are age-associated neurodegenerative diseases whose mechanistic underpinnings remain elusive, partially due to a lack of appropriate human models. Here, we engineered human induced pluripotent stem cell (hiPSC)-derived neuronal lines to express 4R Tau and 4R Tau carrying the P301S MAPT mutation when differentiated into neurons. 4R-P301S neurons display progressive Tau inclusions upon seeding with Tau fibrils and recapitulate features of tauopathy phenotypes including shared transcriptomic signatures, autophagic body accumulation, and reduced neuronal activity. A CRISPRi screen of genes associated with Tau pathobiology identified over 500 genetic modifiers of seeding-induced Tau propagation, including retromer VPS29 and genes in the UFMylation cascade. In progressive supranuclear palsy (PSP) and Alzheimer's Disease (AD) brains, the UFMylation cascade is altered in neurofibrillary-tangle-bearing neurons. Inhibiting the UFMylation cascade in vitro and in vivo suppressed seeding-induced Tau propagation. This model provides a robust platform to identify novel therapeutic strategies for 4R tauopathy.

Authors

AM Giani,JM Perez,Z Zhao,Y Wan,AJ Samelson,MY Wong,A Evangelisti,E Cordes,L Fan,P Ye,D Zhu,T Pozner,M Mercedes,T Patel,A Yarahmady,GK Carling,FH Sterky,VMY Lee,EB Lee,M DeTure,DW Dickson,M Sharma,SA Mok,W Luo,M Zhao,M Kampmann,S Gong,L Gan

Journal

Cell

Published Date

2024/3/28

Highly tunable bimane-based fluorescent probes: design, synthesis, and application as a selective amyloid binding dye

Small molecule fluorescent probes are indispensable tools for a broad range of biological applications. Despite many probes being available, there is still a need for probes where photophysical properties and biological selectivity can be tuned as desired. Here, we report the rational design and synthesis of a palette of fluorescent probes based on the underexplored bimane scaffold. The newly developed probes with varied electronic properties show tunable absorption and emission in the visible region with large Stokes shifts. Probes featuring electron-donating groups exhibit rotor effects that are sensitive to polarity and viscosity by “intramolecular charge transfer” (ICT) and twisted intramolecular charge transfer (TICT) mechanisms, respectively. These properties enable their application as “turn-on” fluorescent probes to detect fibrillar aggregates of the α-synuclein (αS) protein that are a hallmark of Parkinson's …

Authors

Yarra Venkatesh,Nicholas P Marotta,Virginia M-Y Lee,E James Petersson

Journal

Chemical Science

Published Date

2024

LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression

BackgroundMutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease (PD). These mutations elevate the LRRK2 kinase activity, making LRRK2 kinase inhibitors an attractive therapeutic. LRRK2 kinase activity has been consistently linked to specific cell signaling pathways, mostly related to organelle trafficking and homeostasis, but its relationship to PD pathogenesis has been more difficult to define. LRRK2-PD patients consistently present with loss of dopaminergic neurons in the substantia nigra but show variable development of Lewy body or tau tangle pathology. Animal models carrying LRRK2 mutations do not develop robust PD-related phenotypes spontaneously, hampering the assessment of the efficacy of LRRK2 inhibitors against disease processes. We hypothesized that mutations in LRRK2 may not be directly related to a single disease pathway, but …

Authors

Noah Lubben,Julia K Brynildsen,Connor M Webb,Howard L Li,Cheryl EG Leyns,Lakshmi Changolkar,Bin Zhang,Emily S Meymand,Mia O’Reilly,Zach Madaj,Daniella DeWeerd,Matthew J Fell,Virginia MY Lee,Dani S Bassett,Michael X Henderson

Journal

Translational Neurodegeneration

Published Date

2024/3/4

ScISOr-ATAC reveals convergent and divergent splicing and chromatin specificities between matched cell types across cortical regions, evolution, and in Alzheimer's disease.

Multimodal measurements have become widespread in genomics, however measuring open chromatin accessibility and splicing simultaneously in frozen brain tissues remains unconquered. Hence, we devised Single-Cell-ISOform-RNA sequencing coupled with the Assay-for-Transposase-Accessible-Chromatin (ScISOr-ATAC). We utilized ScISOr-ATAC to assess whether chromatin and splicing alterations in the brain convergently affect the same cell types or divergently different ones. We applied ScISOr-ATAC to three major conditions: comparing (i) the Rhesus macaque (Macaca mulatta) prefrontal cortex (PFC) and visual cortex (VIS), (ii) cross species divergence of Rhesus macaque versus human PFC, as well as (iii) dysregulation in Alzheimer's disease in human PFC. We found that among cortical-layer biased excitatory neuron subtypes, splicing is highly brain-region specific for L3-5/L6 IT_RORB neurons, moderately specific in L2-3 IT_CUX2.RORB neurons and unspecific in L2-3 IT_CUX2 neurons. In contrast, at the chromatin level, L2-3 IT_CUX2.RORB neurons show the highest brain-region specificity compared to other subtypes. Likewise, when comparing human and macaque PFC, strong evolutionary divergence on one molecular modality does not necessarily imply strong such divergence on another molecular level in the same cell type. Finally, in Alzheimer's disease, oligodendrocytes show convergently high dysregulation in both chromatin and splicing. However, chromatin and splicing dysregulation most strongly affect distinct oligodendrocyte subtypes. Overall, these results indicate that chromatin and splicing can show …

Authors

Wen Hu,Careen Foord,Justine Hsu,Li Fan,Michael J Corley,Tarun N Bhatia,Siwei Xu,Natan Belchikov,Yi He,Alina PS Pang,Samantha N Lanjewar,Julien Jarroux,Anoushka Joglekar,Teresa A Milner,Lishomwa Ndhlovu,Jing Zhang,Eduardo Butelman,Steven A Sloan,Virginia MY Lee,Li Gan,Hagen U Tilgner

Journal

bioRxiv

Published Date

2024

Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease

Objective Alzheimer's disease neuropathologic change and alpha‐synucleinopathy commonly co‐exist and contribute to the clinical heterogeneity of dementia. Here, we examined tau epitopes marking various stages of tangle maturation to test the hypotheses that tau maturation is more strongly associated with beta‐amyloid compared to alpha‐synuclein, and within the context of mixed pathology, mature tau is linked to Alzheimer's disease clinical phenotype and negatively associated with Lewy body dementia. Methods We used digital histology to measure percent area‐occupied by pathology in cortical regions among individuals with pure Alzheimer's disease neuropathologic change, pure alpha‐synucleinopathy, and a co‐pathology group with both Alzheimer's and alpha‐synuclein pathologic diagnoses. Multiple tau monoclonal antibodies were used to detect early (AT8, MC1) and mature (TauC3) epitopes of …

Authors

Sanaz Arezoumandan,Katheryn AQ Cousins,Daniel T Ohm,MaKayla Lowe,Min Chen,James Gee,Jeffrey S Phillips,Corey T McMillan,Kelvin C Luk,Andres Deik,Meredith A Spindler,Thomas F Tropea,Daniel Weintraub,David A Wolk,Murray Grossman,Virginia Lee,Alice S Chen‐Plotkin,Edward B Lee,David J Irwin

Journal

Annals of Clinical and Translational Neurology

Published Date

2024/3

MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons

Inclusions comprised of microtubule-associated protein tau (tau) are implicated in a group of neurodegenerative diseases, collectively known as tauopathies, that include Alzheimer’s disease (AD). The spreading of misfolded tau “seeds” along neuronal networks is thought to play a crucial role in the progression of tau pathology. Consequently, restricting the release or uptake of tau seeds may inhibit the spread of tau pathology and potentially halt the advancement of the disease. Previous studies have demonstrated that the Mammalian Suppressor of Tauopathy 2 (MSUT2), an RNA binding protein, modulates tau pathogenesis in a transgenic mouse model. In this study, we investigated the impact of MSUT2 on tau pathogenesis using tau seeding models. Our findings indicate that the loss of MSUT2 mitigates human tau seed-induced pathology in neuron cultures and mouse models. In addition, MSUT2 regulates …

Authors

Hong Xu,Qi Qiu,Peng Hu,Kevt’her Hoxha,Elliot Jang,Mia O’Reilly,Christopher Kim,Zhuohao He,Nicholas Marotta,Lakshmi Changolkar,Bin Zhang,Hao Wu,Gerard D Schellenberg,Brian Kraemer,Kelvin C Luk,Edward B Lee,John Q Trojanowski,Kurt R Brunden,Virginia M-Y Lee

Journal

Acta Neuropathologica

Published Date

2024/6

O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathology

Amyloid-forming proteins such α-synuclein and tau, which are implicated in Alzheimer’s and Parkinson’s disease, can form different fibril structures or strains with distinct toxic properties, seeding activities and pathology. Understanding the determinants contributing to the formation of different amyloid features could open new avenues for developing disease-specific diagnostics and therapies. Here we report that O-GlcNAc modification of α-synuclein monomers results in the formation of amyloid fibril with distinct core structure, as revealed by cryogenic electron microscopy, and diminished seeding activity in seeding-based neuronal and rodent models of Parkinson’s disease. Although the mechanisms underpinning the seeding neutralization activity of the O-GlcNAc-modified fibrils remain unclear, our in vitro mechanistic studies indicate that heat shock proteins interactions with O-GlcNAc fibril inhibit their seeding …

Authors

Aaron T Balana,Anne-Laure Mahul-Mellier,Binh A Nguyen,Mian Horvath,Afraah Javed,Eldon R Hard,Yllza Jasiqi,Preeti Singh,Shumaila Afrin,Rose Pedretti,Virender Singh,Virginia M-Y Lee,Kelvin C Luk,Lorena Saelices,Hilal A Lashuel,Matthew R Pratt

Journal

Nature chemical biology

Published Date

2024/2/12

The Adaptive Immune System Is Not Necessary for α-synuclein Pathology Formation or Dopaminergic Neuron Loss After α-synuclein Pre-formed Fibril Injection (P7-3.008)

Objective To understand the role of the adaptive immune (B & T cells) and innate immune systems (i.e. microglia) in Parkinson’s Disease (PD) pathogenesis. Background Intracellular aggregates of the protein α-synuclein (asyn) pathologically define PD, and mutations of asyn genetically link asyn to PD. Microglia, the chief immune cell of the CNS, and B & T cell activity have been implicated in PD neurodegeneration. How neuroinflammation mediated by these cells is involved in PD pathogenesis is a key knowledge gap. Design/Methods I utilized 2 mouse lines that exhibit varying dysfunctional immune activity and C57BL/6 mice, which have intact adaptive and innate immune function. Rag2;IL2Rγ double knockout (RDKO) mice lack B & T cells and Non-obese Diabetic SCID Gamma (NSG) mice lack B & T cells and also contain innate immune dysregulation. I injected all 3 mouse strains intracerebrally with a …

Authors

Esteban Luna,Bin Zhang,Virginia Lee,Kelvin Luk

Published Date

2024/4/14

academic-engine

Useful Links